{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:23:40Z","timestamp":1793766220541,"version":"4.6.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:00:00Z","timestamp":1569974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:00:00Z","timestamp":1569974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We aimed to identify global blood and retinal gene expression patterns in murine oxygen-induced retinopathy (OIR), a common model of retinopathy of prematurity, which may allow better understanding of the pathogenesis of this severe ocular prematurity complication and identification of potential blood biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 120\u00a0C57BL\/6J mice were randomly divided into an OIR group, in which 7-day-old pups were maintained in 75% oxygen for 5\u00a0days, or a control group. RNA was extracted from the whole-blood mononuclear cells and retinal cells on days 12, 17, and 28. Gene expression in the RNA samples was evaluated with mouse gene expression microarrays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were 38,\u00a01370 and 111 genes, the expression of which differed between the OIR and control retinas on days 12, 17, and 28, respectively. Gene expression in the blood mononuclear cells was significantly altered only on day 17.\n                      <jats:italic>Deptor<\/jats:italic>\n                      and\n                      <jats:italic>Nol4<\/jats:italic>\n                      genes showed reduced expression both in the blood and retinal cells on day 17.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      There are sustained marked changes in the global pattern of gene expression in the OIR mice retinas. An altered expression of\n                      <jats:italic>Deptor<\/jats:italic>\n                      and\n                      <jats:italic>Nol4<\/jats:italic>\n                      genes in the blood mononuclear cells requires further investigation as they may indicate retinal neovascularization.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-019-0598-y","type":"journal-article","created":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T06:06:02Z","timestamp":1569996362000},"page":"485-493","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Short- and long-term impact of hyperoxia on the blood and retinal cells\u2019 transcriptome in a mouse model of oxygen-induced retinopathy"],"prefix":"10.1038","volume":"87","author":[{"given":"Magdalena","family":"Zasada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Madetko-Talowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie","family":"Revhaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Gro W.","family":"Rognlien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars O.","family":"Baumbusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teofila","family":"Ksi\u0105\u017cek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Szewczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Grabowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslaw","family":"Bik-Multanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"J\u00f3zef Pietrzyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemko","family":"Kwinta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola Didrik","family":"Saugstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,2]]},"reference":[{"key":"598_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/pr.2013.205","volume":"Suppl 1","author":"H Blencowe","year":"2013","unstructured":"Blencowe, H. et al. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr. Res. Suppl 1, 35\u201349 (2013).","journal-title":"Pediatr. Res."},{"key":"598_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/aos.12049","volume":"92","author":"G Cavallaro","year":"2014","unstructured":"Cavallaro, G. et al. The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge. Acta Ophthalmol. 92, 2\u201320 (2014).","journal-title":"Acta Ophthalmol."},{"key":"598_CR3","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/nprot.2009.187","volume":"4","author":"KM Connor","year":"2009","unstructured":"Connor, K. M. et al. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat. Protoc. 4, 1565\u20131573 (2009).","journal-title":"Nat. Protoc."},{"key":"598_CR4","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1172\/JCI42142","volume":"120","author":"P Sapieha","year":"2010","unstructured":"Sapieha, P. et al. Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life. J. Clin. Invest. 120, 3022\u20133032 (2010).","journal-title":"J. Clin. Invest."},{"key":"598_CR5","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1056\/NEJMra1208129","volume":"367","author":"ME Hartnett","year":"2012","unstructured":"Hartnett, M. E. & Penn, J. S. Mechanisms and management of retinopathy of prematurity. N. Engl. J. Med. 367, 2515\u20132526 (2012).","journal-title":"N. Engl. J. Med."},{"key":"598_CR6","first-page":"101","volume":"35","author":"LE Smith","year":"1994","unstructured":"Smith, L. E. et al. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35, 101\u2013111 (1994).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"598_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/bjo.2008.142646","volume":"93","author":"T Sato","year":"2009","unstructured":"Sato, T. et al. Comprehensive gene-expression profile in murine oxygen-induced retinopathy. Br. J. Ophthalmol. 93, 96\u2013103 (2009).","journal-title":"Br. J. Ophthalmol."},{"key":"598_CR8","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1167\/iovs.09-4605","volume":"51","author":"K Ishikawa","year":"2010","unstructured":"Ishikawa, K. et al. Gene expression profile of hyperoxic and hypoxic retinas in a mouse model of oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 51, 4307\u20134319 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"598_CR9","first-page":"775","volume":"19","author":"X Yang","year":"2013","unstructured":"Yang, X., Dong, X., Jia, C. & Wang, Y. Profiling of genes associated with the murine model of oxygen-induced retinopathy. Mol. Vis. 19, 775\u2013788 (2013).","journal-title":"Mol. Vis."},{"key":"598_CR10","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1167\/iovs.09-4006","volume":"51","author":"FM Recchia","year":"2010","unstructured":"Recchia, F. M. et al. Identification of genes and pathways involved in retinal neovascularization by microarray analysis of two animal models of retinal angiogenesis. Invest. Ophthalmol. Vis. Sci. 51, 1098\u20131105 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"598_CR11","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/pr.2012.195","volume":"73","author":"JJ Pietrzyk","year":"2013","unstructured":"Pietrzyk, J. J. et al. New insight into the pathogenesis of retinopathy of prematurity: assessment of whole-genome expression. Pediatr. Res. 73, 476\u2013483 (2013).","journal-title":"Pediatr. Res."},{"key":"598_CR12","doi-asserted-by":"publisher","first-page":"e18160","DOI":"10.1371\/journal.pone.0018160","volume":"6","author":"S Maltby","year":"2011","unstructured":"Maltby, S. et al. Opposing roles for CD34 in B16 melanoma tumor growth alter early stage vasculature and late stage immune cell infiltration. PLoS ONE 6, e18160 (2011).","journal-title":"PLoS ONE"},{"key":"598_CR13","doi-asserted-by":"publisher","first-page":"e0157902","DOI":"10.1371\/journal.pone.0157902","volume":"11","author":"MJ Siemerink","year":"2016","unstructured":"Siemerink, M. J. et al. CD34 promotes pathological epi-retinal neovascularization in a mouse model of oxygen-induced retinopathy. PLoS ONE 11, e0157902 (2016).","journal-title":"PLoS ONE"},{"key":"598_CR14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1161\/CIRCRESAHA.115.304718","volume":"115","author":"SF Rocha","year":"2014","unstructured":"Rocha, S. F. et al. Esm1 modulates endothelial tip cell behavior and vascular permeability by enhancing VEGF bioavailability. Circ. Res. 115, 581\u2013590 (2014).","journal-title":"Circ. Res."},{"key":"598_CR15","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/s41433-018-0032-4","volume":"32","author":"FS Sorrentino","year":"2018","unstructured":"Sorrentino, F. S. et al. Diabetic retinopathy and endothelin system: microangiopathy versus endothelial dysfunction. Eye (Lond.). 32, 1157\u20131163 (2018).","journal-title":"Eye (Lond.)."},{"key":"598_CR16","doi-asserted-by":"publisher","first-page":"E3830","DOI":"10.1073\/pnas.1315509110","volume":"110","author":"A Rattner","year":"2013","unstructured":"Rattner, A. et al. Endothelin-2 signaling in the neural retina promotes the endothelial tip cell state and inhibits angiogenesis. Proc. Natl Acad. Sci. USA. 110, E3830\u2013E3839 (2013).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"598_CR17","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1016\/j.ajpath.2014.07.012","volume":"184","author":"C Patel","year":"2014","unstructured":"Patel, C. et al. Activation of the endothelin system mediates pathological angiogenesis during ischemic retinopathy. Am. J. Pathol. 184, 3040\u20133051 (2014).","journal-title":"Am. J. Pathol."},{"key":"598_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s12177-011-9072-8","volume":"4","author":"JJ Blom","year":"2011","unstructured":"Blom, J. J. et al. Inhibition of the adrenomedullin\/nitric oxide signaling pathway in early diabetic retinopathy. J. Ocul. Biol. Dis. Info. 4, 70\u201382 (2011).","journal-title":"J. Ocul. Biol. Dis. Info."},{"key":"598_CR19","first-page":"1971","volume":"41","author":"E Rungger-Br\u00e4ndle","year":"2000","unstructured":"Rungger-Br\u00e4ndle, E., Dosso, A. A. & Leuenberger, P. M. Glial reactivity, an early feature of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 41, 1971\u20131980 (2000).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"598_CR20","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1161\/ATVBAHA.110.209775","volume":"30","author":"A Kasai","year":"2010","unstructured":"Kasai, A. et al. Apelin is a crucial factor for hypoxia-induced retinal angiogenesis. Arterioscler. Thromb. Vasc. Biol. 30, 2182\u20132187 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"598_CR21","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1161\/ATVBAHA.108.174847","volume":"28","author":"Y Kojima","year":"2008","unstructured":"Kojima, Y. & Quertermous, T. Apelin-APJ signaling in retinal angiogenesis. Arterioscler. Thromb. Vasc. Biol. 28, 1687\u20131688 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"598_CR22","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1161\/CIRCRESAHA.108.179333","volume":"103","author":"M Eyries","year":"2008","unstructured":"Eyries, M. et al. Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis. Circ. Res. 103, 432\u2013440 (2008).","journal-title":"Circ. Res."},{"key":"598_CR23","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1167\/iovs.09-4466","volume":"51","author":"Y Tao","year":"2010","unstructured":"Tao, Y. et al. Apelin in plasma and vitreous and in fibrovascular retinal membranes of patients with proliferative diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 51, 4237\u20134242 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"598_CR24","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1161\/ATVBAHA.108.163402","volume":"28","author":"A Kasai","year":"2008","unstructured":"Kasai, A. et al. Retardation of retinal vascular development in apelin-deficient mice. Arterioscler. Thromb. Vasc. Biol. 28, 1717\u20131722 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"598_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/cvr\/cvt170","volume":"100","author":"O Watson","year":"2013","unstructured":"Watson, O. et al. Blood flow suppresses vascular Notch signalling via dll4 and is required for angiogenesis in response to hypoxic signalling. Cardiovasc. Res. 100, 252\u2013261 (2013).","journal-title":"Cardiovasc. Res."},{"key":"598_CR26","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1091\/mbc.e11-05-0393","volume":"22","author":"AC Newman","year":"2011","unstructured":"Newman, A. C. et al. The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation. Mol. Biol. Cell. 22, 3791\u20133800 (2011).","journal-title":"Mol. Biol. Cell."},{"key":"598_CR27","doi-asserted-by":"publisher","first-page":"2180819","DOI":"10.1155\/2017\/2180819","volume":"2017","author":"SCT Corbi","year":"2017","unstructured":"Corbi, S. C. T. et al. Expression profile of genes potentially associated with adequate glycemic control in patients with type 2 diabetes mellitus. J. Diabetes Res. 2017, 2180819 (2017).","journal-title":"J. Diabetes Res."},{"key":"598_CR28","doi-asserted-by":"publisher","first-page":"1356 68","DOI":"10.1016\/j.neurobiolaging.2014.11.020","volume":"36","author":"CY Ko","year":"2015","unstructured":"Ko, C. Y. et al. CCAAT\/enhancer-binding protein delta\/miR135a\/thrombospondin 1 axis mediates PGE2-induced angiogenesis in Alzheimer's disease. Neurobiol. Aging 36, 1356 68 (2015).","journal-title":"Neurobiol. Aging"},{"key":"598_CR29","first-page":"1983","volume":"14","author":"R Natoli","year":"2008","unstructured":"Natoli, R., Provis, J., Valter, K. & Stone, J. Gene regulation induced in the C57BL\/6J mouse retina by hyperoxia: a temporal microarray study. Mol. Vis. 14, 1983\u20131994 (2008).","journal-title":"Mol. Vis."},{"key":"598_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nm0402-349","volume":"8","author":"OV Volpert","year":"2002","unstructured":"Volpert, O. V. et al. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat. Med. 8, 349\u2013357 (2002).","journal-title":"Nat. Med."},{"key":"598_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0868-8","volume":"14","author":"PA Williams","year":"2017","unstructured":"Williams, P. A. et al. GlyCAM1 negatively regulates monocyte entry into the optic nerve head and contributes to radiation-based protection in glaucoma. J. Neuroinflammation. 14, 93 (2017).","journal-title":"J. Neuroinflammation."},{"key":"598_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1006\/geno.1996.4507","volume":"39","author":"K Motoki","year":"1997","unstructured":"Motoki, K., Megahed, M., LaForgia, S. & Uitto, J. Cloning and chromosomal mapping of mouse ladinin, a novel basement membrane zone component. Genomics 39, 323\u2013330 (1997).","journal-title":"Genomics"},{"key":"598_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-4-40","volume":"4","author":"GV Bixler","year":"2011","unstructured":"Bixler, G. V. et al. Chronic insulin treatment of diabetes does not fully normalize alterations in the retinal transcriptome. BMC Med. Genomics. 4, 40 (2011).","journal-title":"BMC Med. Genomics."},{"key":"598_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1167\/iovs.14-15616","volume":"56","author":"L Fang","year":"2014","unstructured":"Fang, L., Barber, A. J. & Shenberger, J. S. Regulation of fibroblast growth factor 2 expression in oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 56, 207\u2013215 (2014).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"598_CR35","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/978-1-4614-3209-8_101","volume":"801","author":"T Sasore","year":"2014","unstructured":"Sasore, T., Reynolds, A. L. & Kennedy, B. N. Targeting the PI3K\/Akt\/mTOR pathway in ocular neovascularization. Adv. Exp. Med. Biol. 801, 805\u2013811 (2014).","journal-title":"Adv. Exp. Med. Biol."},{"key":"598_CR36","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1248\/bpb.b17-00475","volume":"40","author":"T Nakahara","year":"2017","unstructured":"Nakahara, T. et al. Mammalian target of rapamycin (mTOR) as a potential therapeutic target in pathological ocular angiogenesis. Biol. Pharm. Bull. 40, 2045\u20132049 (2017).","journal-title":"Biol. Pharm. Bull."},{"key":"598_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/bbrc.1998.9606","volume":"252","author":"N Ueki","year":"1998","unstructured":"Ueki, N. et al. NOLP: identification of a novel human nucleolar protein and determination of sequence requirements for its nucleolar localization. Biochem. Biophys. Res. Commun. 252, 97\u2013102 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"598_CR38","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1158\/0008-5472.CAN-07-3194","volume":"68","author":"SS Wang","year":"2008","unstructured":"Wang, S. S. et al. Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. Cancer Res. 68, 2489\u20132497 (2008).","journal-title":"Cancer Res."},{"key":"598_CR39","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3892\/or.2013.2927","volume":"31","author":"S Demokan","year":"2014","unstructured":"Demokan, S. et al. Validation of nucleolar protein 4 as a novel methylated tumor suppressor gene in head and neck cancer. Oncol. Rep. 31, 1014\u20131020 (2014).","journal-title":"Oncol. Rep."},{"key":"598_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1165\/ajrcmb.18.1.2950m","volume":"18","author":"MA O'Reilly","year":"1998","unstructured":"O'Reilly, M. A., Staversky, R. J., Stripp, B. R. & Finkelstein, J. N. Exposure to hyperoxia induces p53 expression in mouse lung epithelium. Am. J. Respir. Cell Mol. Biol. 18, 43\u201350 (1998).","journal-title":"Am. J. Respir. Cell Mol. Biol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0598-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0598-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0598-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:28:15Z","timestamp":1684603695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0598-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,2]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["598"],"URL":"https:\/\/doi.org\/10.1038\/s41390-019-0598-y","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,2]]},"assertion":[{"value":"3 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}